Company

Gliknik

Rocket Ship Rating

Rocket Ship Rating: 95 out of 100

Also known as Gliknik Inc

Biotech & therapeutics

Business model: B2B
Legal name: Gliknik Inc

gliknik.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 29 September 2026

About

Gliknik develops innovative biologics and therapies to fight cancer, disease, and autoimmune disorders.

Funding snapshot

Total raised: $50.7MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
Latest round: Round, $15M2025-08-15

Funding rounds

Round, 2025: $15M2025-08-15, SEC form D sold, 9 investors
Round, 2024: $5.3M2024-11-06, SEC form D sold, 25 investors
Round, 2023: $9.2M2023-06-29, SEC form D sold, 23 investors
Round, 2021: $4.3M2021-05-20, SEC form D sold, 4 investors
Round, 2013: $2.8M2013-09-03, SEC form D sold, 13 investors
Round, 2012: $9.9M2012-08-13, SEC form D sold, 27 investors
Round, 2011: $2M2011-08-24, SEC form D sold, 21 investors
Round, 2010: $850K2010-12-21, SEC form D sold, 6 investors
Round, 2010: $2.4M2010-08-17, SEC form D sold, 15 investors
Round, 2008: $2.9M2008-08-19, SEC form D sold, 23 investors